Table 1 Baseline characteristics of all patients
Variables | N = 173 |
|---|---|
Age (range) | 63.8 (25.0–84.0) |
Sex (female / male) | 86 (49.7%) / 87 (50.3%) |
ECOG (0 / 1 / 2) | 36 (20.8%) / 126 (72.8%) / 11 (6.4%) |
BMI | 23.0 ± 2.8 |
Charlson comorbidity index | 8.0 ± 1.4 |
Stage (IIIB / IVA / IVB) | 1 (0.6%) / 8 (4.6%) / 164 (94.8%) |
Invasion | |
 Liver | 47 (27.2%) |
 Extrahepatic bile duct | 26 (15.0%) |
 Intestine | 20 (11.6%) |
 Peritoneum | 2 (1.2%) |
 Hepatic artery | 15 (8.7%) |
 Main portal vein | 11 (6.4%) |
Metastasis | |
 Liver | 74 (42.8%) |
 Peritoneum | 46 (26.6%) |
 Lung | 29 (16.8%) |
 Bone or muscular system | 14 (8.1%) |
 Distant lymph node | 102 (59.0%) |
Previous history | |
 Biliary drainage | 49 (28.3%) |
 Curative surgery | 33 (19.1%) |
 Palliative chemotherapy | 12 (8.5%) |
Baseline laboratory findings | |
 WBC (cells/μL) | 6540.0 ± 5192.4 |
 CRP (mg/dL) | 3.5 ± 4.0 |
 eGFR (mL/min/1.73m2) | 92.8 ± 23.1 |
 AST (IU/L) | 40.3 ± 40.3 |
 ALT (IU/L) | 44.2 ± 50.8 |
 ALP (IU/L) | 183.7 ± 174.9 |
 Bilirubin, total (mg/dL) | 1.5 ± 2.4 |
 CEA (ng/mL) | 68.6 ± 247.7 |
 CA 19–9 (U/mL) | 2676.9 ± 6783.1 |
 NLR | 4.2 ± 3.4 |
 PLR | 189.0 ± 95.0 |